This brand name is authorized in Austria, Germany, Estonia, Spain, France, Croatia, Ireland, Italy, Lithuania, Poland, South Africa
The drug REVINTY ELLIPTA contains a combination of these active pharmaceutical ingredients (APIs):
|
1
Fluticasone furoate
UNII JS86977WNV - FLUTICASONE FUROATE
|
|
Fluticasone furoate is a synthetic trifluorinated corticosteroid that possesses a very high affinity for the glucocorticoid receptor and has a potent anti-inflammatory action. |
|
2
Vilanterol
UNII 40AHO2C6DG - VILANTEROL TRIFENATATE
|
|
Vilanterol is a selective long-acting, beta2-adrenergic agonist (LABA). The pharmacologic effects of beta2-adrenoceptor agonist active substances, including vilanterol, are at least in part attributable to stimulation of intracellular adenylate cyclase, the enzyme that catalyzes the conversion of adenosine triphosphate (ATP) to cyclic-3',5'-adenosine monophosphate (cyclic AMP). Increased cyclic AMP levels cause relaxation of bronchial smooth muscle and inhibition of release of mediators of immediate hypersensitivity from cells, especially from mast cells. |
Below package inserts are available for further reading:
| Title | Information Source | Document Type | |
|---|---|---|---|
| REVINTY ELLIPTA Inhalation powder, pre-dispensed | European Medicines Agency (EU) | MPI, EU: SmPC |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| R03AK10 | Vilanterol and fluticasone furoate | R Respiratory system → R03 Drugs for obstructive airway diseases → R03A Adrenergics, inhalants → R03AK Adrenergics and other drugs for obstructive airway diseases |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: DE | Bundesinstitut für Arzneimittel und Medizinprodukte | Identifier(s): 10417646, 10417675, 10417681, 10417698, 16741307, 16741313, 16868781, 16868798, 17510857, 17510863, 17623805, 17867789 |
| Country: EE | Ravimiamet | Identifier(s): 1646962, 1646973, 1646984, 1646995, 1647008, 1647019 |
| Country: ES | Centro de información online de medicamentos de la AEMPS | Identifier(s): 114929002, 114929005 |
| Country: FR | Base de données publique des médicaments | Identifier(s): 64050311, 68680154 |
| Country: IT | Agenzia del Farmaco | Identifier(s): 043446018, 043446020, 043446032, 043446044, 043446057, 043446069 |
| Country: LT | Valstybinė vaistų kontrolės tarnyba | Identifier(s): 1073906, 1073907, 1073908, 1073909, 1073910, 1073911 |
| Country: PL | Rejestru Produktów Leczniczych | Identifier(s): 100323094, 100323102 |
| Country: ZA | Health Products Regulatory Authority | Identifier(s): 48/21.5.1/0247, 48/21.5.1/0248 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
